Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsResearchers identified a novel SOX2-BRD4 transcriptional complex driving the expression of GLI1, the final effector of the Hedgehog/GLI (HH/GLI) pathway, providing a novel mechanism of non-canonical Smoothened-independent activation of HH/GLI signaling in melanoma.
[Oncogene]
7753456 EWJW64V7 items 1 apa 0 default asc 1 162043 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-0e3c2fd6f277145f2646ba27a3ecba83%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22EWJW64V7%22%2C%22library%22%3A%7B%22id%22%3A7753456%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pietrobono%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPietrobono%2C%20S.%2C%20Gaudio%2C%20E.%2C%20Gagliardi%2C%20S.%2C%20Zitani%2C%20M.%2C%20Carrassa%2C%20L.%2C%20Migliorini%2C%20F.%2C%20Petricci%2C%20E.%2C%20Manetti%2C%20F.%2C%20Makukhin%2C%20N.%2C%20Bond%2C%20A.%20G.%2C%20Paradise%2C%20B.%20D.%2C%20Ciulli%2C%20A.%2C%20Fernandez-Zapico%2C%20M.%20E.%2C%20Bertoni%2C%20F.%2C%20%26amp%3B%20Stecca%2C%20B.%20%282021%29.%20Targeting%20non-canonical%20activation%20of%20GLI1%20by%20the%20SOX2-BRD4%20transcriptional%20complex%20improves%20the%20efficacy%20of%20HEDGEHOG%20pathway%20inhibition%20in%20melanoma.%20%3Ci%3EOncogene%3C%5C%2Fi%3E%2C%201%26%23x2013%3B16.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41388-021-01783-9%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41388-021-01783-9%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D7753456%26amp%3Bitem_key%3DEWJW64V7%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20non-canonical%20activation%20of%20GLI1%20by%20the%20SOX2-BRD4%20transcriptional%20complex%20improves%20the%20efficacy%20of%20HEDGEHOG%20pathway%20inhibition%20in%20melanoma%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Silvia%22%2C%22lastName%22%3A%22Pietrobono%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugenio%22%2C%22lastName%22%3A%22Gaudio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sinforosa%22%2C%22lastName%22%3A%22Gagliardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariapaola%22%2C%22lastName%22%3A%22Zitani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Carrassa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesca%22%2C%22lastName%22%3A%22Migliorini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elena%22%2C%22lastName%22%3A%22Petricci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabrizio%22%2C%22lastName%22%3A%22Manetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nikolai%22%2C%22lastName%22%3A%22Makukhin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20G.%22%2C%22lastName%22%3A%22Bond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brooke%20D.%22%2C%22lastName%22%3A%22Paradise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessio%22%2C%22lastName%22%3A%22Ciulli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20E.%22%2C%22lastName%22%3A%22Fernandez-Zapico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francesco%22%2C%22lastName%22%3A%22Bertoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Stecca%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20the%20development%20of%20new%20targeted%20and%20immune%20therapies%2C%20the%20prognosis%20of%20metastatic%20melanoma%20remains%20bleak.%20Therefore%2C%20it%20is%20critical%20to%20better%20understand%20the%20mechanisms%20controlling%20advanced%20melanoma%20to%20develop%20more%20effective%20treatment%20regimens.%20Hedgehog%5C%2FGLI%20%28HH%5C%2FGLI%29%20signaling%20inhibitors%20targeting%20the%20central%20pathway%20transducer%20Smoothened%20%28SMO%29%20have%20shown%20to%20be%20clinical%20efficacious%20in%20skin%20cancer%3B%20however%2C%20several%20mechanisms%20of%20non-canonical%20HH%5C%2FGLI%20pathway%20activation%20limit%20their%20efficacy.%20Here%2C%20we%20identify%20a%20novel%20SOX2-BRD4%20transcriptional%20complex%20driving%20the%20expression%20of%20GLI1%2C%20the%20final%20effector%20of%20the%20HH%5C%2FGLI%20pathway%2C%20providing%20a%20novel%20mechanism%20of%20non-canonical%20SMO-independent%20activation%20of%20HH%5C%2FGLI%20signaling%20in%20melanoma.%20Consistently%2C%20we%20find%20a%20positive%20correlation%20between%20the%20expression%20of%20GLI1%20and%20SOX2%20in%20human%20melanoma%20samples%20and%20cell%20lines.%20Further%2C%20we%20show%20that%20combined%20targeting%20of%20canonical%20HH%5C%2FGLI%20pathway%20with%20the%20SMO%20inhibitor%20MRT-92%20and%20of%20the%20SOX2-BRD4%20complex%20using%20a%20potent%20Proteolysis%20Targeted%20Chimeras%20%28PROTACs%29-derived%20BRD4%20degrader%20%28MZ1%29%2C%20yields%20a%20synergistic%20anti-proliferative%20effect%20in%20melanoma%20cells%20independently%20of%20their%20BRAF%2C%20NRAS%2C%20and%20NF1%20mutational%20status%2C%20with%20complete%20abrogation%20of%20GLI1%20expression.%20Combination%20of%20MRT-92%20and%20MZ1%20strongly%20potentiates%20the%20antitumor%20effect%20of%20either%20drug%20as%20single%20agents%20in%20an%20orthotopic%20melanoma%20model.%20Together%2C%20our%20data%20provide%20evidence%20of%20a%20novel%20mechanism%20of%20non-canonical%20activation%20of%20GLI1%20by%20the%20SOX2-BRD4%20transcriptional%20complex%2C%20and%20describe%20the%20efficacy%20of%20a%20new%20combinatorial%20treatment%20for%20a%20subset%20of%20melanomas%20with%20an%20active%20SOX2-BRD4-GLI1%20axis.%22%2C%22date%22%3A%222021-05-06%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41388-021-01783-9%22%2C%22ISSN%22%3A%221476-5594%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41388-021-01783-9%22%2C%22deleted%22%3A1%2C%22collections%22%3A%5B%22DUPVZUHA%22%5D%2C%22dateModified%22%3A%222021-05-06T17%3A19%3A44Z%22%7D%7D%5D%7D
Pietrobono, S., Gaudio, E., Gagliardi, S., Zitani, M., Carrassa, L., Migliorini, F., Petricci, E., Manetti, F., Makukhin, N., Bond, A. G., Paradise, B. D., Ciulli, A., Fernandez-Zapico, M. E., Bertoni, F., & Stecca, B. (2021). Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma. Oncogene, 1–16. https://doi.org/10.1038/s41388-021-01783-9 Cite
